DMK
David M. Knott Portfolio holdings
AUM
$264M
This Quarter Return
+2.31%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(-7%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-7.57%
Top 10 Holdings %
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
14
Reduced
10
Closed
4
Top Buys
| 1 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
$1.42M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.37M |
| 3 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
$1.25M |
| 4 |
TG Therapeutics
TGTX
|
$1.04M |
| 5 |
FibroGen
FGEN
|
$811K |
Top Sells
| 1 |
SRCL
Stericycle Inc
SRCL
|
$6.88M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$3.75M |
| 3 |
KKR & Co
KKR
|
$2.75M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$2.47M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$2.38M |
Sector Composition
| 1 | Healthcare | 39.75% |
| 2 | Financials | 16.69% |
| 3 | Industrials | 12.97% |
| 4 | Technology | 9.75% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAPO
26
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.42M | 0.83% |
+49,000
| New | +$1.42M |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.37M | 0.81% |
+12,000
| New | +$1.37M |
|
28
AllianceBernstein
AB
$4.37B
| $1.37M | 0.8% |
50,500
| – | – |
|
29
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.37M | 0.8% |
397,361
| – | – |
|
|
30
TG Therapeutics
TGTX
$5.03B
| $1.36M | 0.8% |
50,773
+38,773
| +323% | +$1.04M |
|
31
Viking Therapeutics
VKTX
$3.02B
| $1.27M | 0.74% |
218,102
| – | – |
|
|
MDWT
32
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $1.25M | 0.73% |
+83,344
| New | +$1.25M |
|
|
BRSL
33
Brightstar Lottery PLC
BRSL
$3.09B
| $1.2M | 0.7% |
107,500
| – | – |
|
34
Cidara Therapeutics
CDTX
$1.61B
| $1.16M | 0.68% |
407,061
| – | – |
|
35
uniQure
QURE
$954M
| $1.14M | 0.67% |
31,000
+10,642
| +52% | +$392K |
|
36
Verizon
VZ
$184B
| $1.09M | 0.64% |
18,311
| – | – |
|
37
Johnson & Johnson
JNJ
$429B
| $1.08M | 0.64% |
7,280
| – | – |
|
38
Mondelez International
MDLZ
$79.3B
| $914K | 0.54% |
15,900
| – | – |
|
39
Kimberly-Clark
KMB
$42.5B
| $886K | 0.52% |
6,000
| – | – |
|
|
40
FibroGen
FGEN
$48.4M
| $811K | 0.48% |
+19,715
| New | +$811K |
|
|
SBBP
41
DELISTED
Strongbridge Biopharma plc.
SBBP
| $781K | 0.46% |
372,000
+75,963
| +26% | +$159K |
|
42
Gilead Sciences
GILD
$140B
| $695K | 0.41% |
+11,000
| New | +$695K |
|
43
DuPont de Nemours
DD
$31.6B
| $672K | 0.39% |
12,118
| – | – |
|
44
Coca-Cola
KO
$297B
| $661K | 0.39% |
13,400
| – | – |
|
45
Alkermes
ALKS
$4.95B
| $630K | 0.37% |
38,000
-20,073
| -35% | -$333K |
|
46
AT&T
T
$208B
| $628K | 0.37% |
22,050
| – | – |
|
47
Collegium Pharmaceutical
COLL
$1.25B
| $622K | 0.36% |
29,862
-39,189
| -57% | -$816K |
|
48
Dow Inc
DOW
$17B
| $570K | 0.33% |
12,118
| – | – |
|
|
RDUS
49
DELISTED
Radius Health, Inc.
RDUS
| $545K | 0.32% |
48,034
+5,000
| +12% | +$56.7K |
|
50
IBM
IBM
$227B
| $521K | 0.31% |
4,284
| – | – |
|